XML 37 R27.htm IDEA: XBRL DOCUMENT v3.22.2

Note 2 - Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2022

Notes Tables

Schedule of Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Table Text Block]

		June 30,				December 31,
		2022				2021
Cash and cash equivalents		$	3,931			$	7,504
Restricted cash included in other assets			155				475
Total cash, cash equivalents, and restricted cash in the condensed consolidated balance sheets		$	4,086			$	7,979

Schedules of Concentration of Risk, by Product [Table Text Block]

		Three Months Ended June 30,								Six Months Ended June 30,
		2022				2021				2022				2021
Avenova		$	1,626			$	1,883			$	3,052			$	3,458
DERMAdoctor			592				—				1,483				—
NeutroPhase			509				175				657				175
Other products			316				68				474				294
Total product revenue, net		3,043					2,126				5,666				3,927
Other revenue, net			2				7				8				13
Total sales, net		$	3,045			$	2,133			$	5,674			$	3,940

Schedules of Concentration of Risk, by Risk Factor [Table Text Block]

		June 30,				December 31,
Major distribution partner		2022				2021
Avenova Spray Pharmacy Distributor A			38	%			11	%
Avenova Spray Pharmacy Distributor B			13	%			13	%
Amazon			12	%			*	%
Major U.S. Retailer A			10	%			*	%
Major U.S. Retailer B			*	%			33	%

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

		Three Months Ended June 30,								Six Months Ended June 30,
Numerator		2022				2021				2022				2021
Net loss		$	(2,155	)		$	(1,859	)		$	(2,266	)		$	(3,377	)
Denominator
Weighted average shares of common stock outstanding, basic and diluted			52,735				42,561				51,419				42,174
Net loss per share, basic and diluted		$	(0.04	)		$	(0.04	)		$	(0.04	)		$	(0.08	)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]

		As of June 30,
		2022				2021
Series B Preferred			29,050				—
Stock options			4,446				3,873
Stock warrants			44,582				7,082
			78,078				10,955

X

- Definition

Tabular disclosure of the components of cash, cash equivalents, restricted cash and restricted cash equivalents.

+ References

No definition available.

+ Details

Name:	nby_ScheduleOfCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsTableTextBlock
Namespace Prefix:	nby_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the concentration of risk by product type.

+ References

No definition available.

+ Details

Name:	nby_SchedulesOfConcentrationOfRiskByProductTableTextBlock
Namespace Prefix:	nby_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

+ Details

Name:	us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-URI https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 20
-URI https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 20
-URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 16
-URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 18
-URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 21
-URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592

+ Details

Name:	us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_TableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration